Dermapharm Holding SE buy Snowman
Start price
16.06.21
/
50%
€71.65
Target price
16.06.22
€86.00
Performance (%)
-30.50%
End price
20.05.22
€49.80
Summary
This prediction ended on 20.05.22 with a price of €49.80. The BUY prediction by Snowman for Dermapharm Holding SE performed very badly with a performance of -30.50%. Snowman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | 1.517% | 1.517% | 18.787% | -15.080% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by Snowman for this prediction
In the thread Dermapharm Holding SE diskutieren
Kursziel geändert auf 86,0